Cary, NC, United States of America

Jun Li

USPTO Granted Patents = 16 

 

Average Co-Inventor Count = 3.7

ph-index = 6

Forward Citations = 58(Granted Patents)


Location History:

  • Melvindale, MI (US) (2003)
  • Raleigh, NC (US) (2015 - 2016)
  • Cary, NC (US) (2015 - 2021)

Company Filing History:


Years Active: 2003-2021

where 'Filed Patents' based on already Granted Patents

16 patents (USPTO):

Title: Innovations and Contributions of Inventor Jun Li

Introduction

Jun Li is a prominent inventor based in Cary, NC, with a remarkable portfolio of 16 patents. His work primarily focuses on drug formulations and innovative methods for cancer diagnosis and treatment. His contributions have significantly advanced the field of pharmacology and biotechnology.

Latest Patents

One of Jun Li's latest patents involves a drug formulation based on particulates comprising a polysaccharide-vitamin conjugate. This formulation provides a novel approach for encapsulating hydrophobic pharmaceutically active agents, such as anti-cancer drugs like paclitaxel. The active agent is strategically placed in the core portion of the particulate, enhancing its effectiveness. The patent also outlines processes for making and using these particulates, which are crucial for developing methods of cancer diagnosis and treatment.

Career Highlights

Throughout his career, Jun Li has worked with notable companies, including Abb Schweiz AG and Lenovo (Singapore) Pte. Ltd. His experience in these organizations has contributed to his expertise in drug formulation and innovative research.

Collaborations

Jun Li has collaborated with several professionals in his field, including Hongrae Kim and Rod D Waltermann. These collaborations have fostered a productive environment for innovation and development in drug formulation technologies.

Conclusion

Jun Li's contributions to the field of pharmacology through his innovative patents and collaborations highlight his significant impact on cancer treatment methodologies. His work continues to inspire advancements in drug formulation and medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…